Literature DB >> 9296315

The contribution of clinical pharmacology surrogates and models to drug development--a critical appraisal.

P Rolan1.   

Abstract

Mesh：

Substances：

Year:  1997        PMID： 9296315      PMCID： PMC2042843          DOI： 10.1046/j.1365-2125.1997.t01-1-00583.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  22 in total

Review 1.  Biomarkers, validation and pharmacokinetic-pharmacodynamic modelling.

Authors:  Wayne A Colburn; Jean W Lee
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

2.  Pharmacokinetic/pharmacodynamic integration in drug development and dosage-regimen optimization for veterinary medicine.

Authors:  Pierre-Louis Toutain
Journal:  AAPS PharmSci       Date:  2002

Review 3.  Biomarkers in systemic lupus erythematosus.

Authors:  Gabor G Illei; Peter E Lipsky
Journal:  Curr Rheumatol Rep       Date:  2004-10       Impact factor: 4.592

4.  A unified procedure for meta-analytic evaluation of surrogate end points in randomized clinical trials.

Authors:  James Y Dai; James P Hughes
Journal:  Biostatistics       Date:  2012-03-06       Impact factor: 5.899

5.  Mechanism-based pharmacokinetic-pharmacodynamic modeling-a new classification of biomarkers.

Authors:  Meindert Danhof; Gunnar Alvan; Svein G Dahl; Jochen Kuhlmann; Gilles Paintaud
Journal:  Pharm Res       Date:  2005-08-24       Impact factor: 4.200

Review 6.  Advancing outcome measures for the new era of drug development in cystic fibrosis.

Authors:  Nicole Mayer-Hamblett; Bonnie W Ramsey; Richard A Kronmal
Journal:  Proc Am Thorac Soc       Date:  2007-08-01

Review 7.  Markers for nutrition studies: review of criteria for the evaluation of markers.

Authors:  Jan de Vries; Jean-Michel Antoine; Tomasz Burzykowski; Alessandro Chiodini; Mike Gibney; Gunter Kuhnle; Agnès Méheust; Loek Pijls; Ian Rowland
Journal:  Eur J Nutr       Date:  2013-08-17       Impact factor: 5.614

8.  Pharmacokinetic modeling of non-linear brain distribution of fluvoxamine in the rat.

Authors:  Marian Geldof; Jan Freijer; Ludy van Beijsterveldt; Meindert Danhof
Journal:  Pharm Res       Date:  2007-08-21       Impact factor: 4.200

9.  Novel diagnostic biomarkers for prostate cancer.

Authors:  Chikezie O Madu; Yi Lu
Journal:  J Cancer       Date:  2010-10-06       Impact factor: 4.207

10.  Validation, reproducibility and safety of trans dermal electrical stimulation in chronic pain patients and healthy volunteers.

Authors:  Remigiusz Lecybyl; Juan Acosta; Joydeep Ghoshdastidar; Kinga Stringfellow; Magdi Hanna
Journal:  BMC Neurol       Date:  2010-01-13       Impact factor: 2.474
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.